ICON, which builds homes using 3D printing, has closed on $56 million in Series C funding co-led by Norwest Venture Partners ...

Vivo Energy has launched a dynamic new corporate brand as a significant milestone to the growth of the company.The new corporate identity includes a bold new brand personality which is confident, ...

Creative OZ-AIR India Pvt Ltd., one of the leading organisation in Ozone, UV, AOP Technology and Air purification solutions, ...

The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033" report has ...

DelveInsight's Biologics Drug Substance Manufacturing Market Insights report provides the current and forecast market ...

The company plans to launch five new biosimilars in the U.S. in the new fiscal year, starting in April, and is aspiring for double-digit market share for them, Biocon Biologics CEO Shreehas Tambe ...

Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a top executive told ...

Biocon plans IPO for biosimilars business by March 2026 Biosimilars are similar and relatively affordable versions of high-priced and complex biologics drugs used to treat illnesses such as cancer ...

Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core US market for its new launches, a top executive told ...

Kiran shares her visionary journey, insights, and innovations in advancing biotechnology through the development of Biocon.

Biocon Biologics has also gained market share, with oncology remaining a key focus area. The company recently received USFDA and European validation for its biosimilar denosumab, used in bone health ...